Low tumor-infiltrating T lymphocytes and a high CD4/CD8 ratio were associated with shorter survival in patients with DLBCL, indicating the crucial role of CD8+ T cells in the TME of DLBCL [38]. The gene discussed is CD8A; the disease is neoplasm.